Blog Posts

Kohei Shitara: DESTINY-Gastric04 demonstrated significantly prolonged OS in gastric cancer

Kohei Shitara/X

Mar 4, 2025, 08:14

Kohei Shitara: DESTINY-Gastric04 demonstrated significantly prolonged OS in gastric cancer

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared a post on X:

“DESTINY-Gastric04 demonstrated significantly prolonged OS with T-DXd vs. PTX+RAM in HER2+ gastric cancer.

A major advancement for patients! Congratulations to all involved!”

cancer DESTINY-Gastric04 gastric cancer Kohei shitara OncoDaily Oncology

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 24, 2025, 01:32

Minhua Chu: Zelgen Biopharma’s ZGGS34 Gets FDA Approval for Solid Tumor Study

Insight

Aug 24, 2025, 01:13

Discovering Approaches to Enhance CAR-NK Cell Antitumor Activity with CRISPR - MD Anderson Cancer Center

Voices

Aug 23, 2025, 23:27

Lauren Kriger Groner: Filming the Cracking Cancer Podcast with The White Ribbon Project

Voices

Aug 23, 2025, 22:57

Paolo Tarantino: Exploring IO and ADC Combinations at SITC25

Drugs

Aug 23, 2025, 22:35

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Voices

Aug 23, 2025, 22:10

Neeraj Agarwal: USPCCC 2025 with Alan H Bryce's Introductory Remarks

Voices

Aug 23, 2025, 21:58

Al-Ola A Abdallah: Reducing Platelet Transfusion Threshold Before LP in Hematologic Malignancy Patients

Voices

Aug 23, 2025, 21:42

Nina Niu Sanford: NRG-GI011 Has Enrolled and Randomized Its 1st Patient

Voices

Aug 23, 2025, 21:31

Rahul Banerjee Shared NEJM Study on Targeted Therapy of CAR+ T-Cell Lymphoma

Societies

Aug 23, 2025, 20:55

Advancing Cancer Treatment with Therapeutic Vaccines - MSKCC

Voices

Aug 23, 2025, 20:22

Joe Taylor's Last Week in the Lab at Fred Hutch Cancer Center - Hsieh Lab

Voices

Aug 23, 2025, 20:12

Sameer Keole Previews ASTRO25: Rediscovering Radiation Medicine and Exploring New Indications